Radiopharmaceuticals
Ended Awarded Last action
- Contract number
- 75N90024F00001
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $993,161
Award facts
- Opportunity
-
- 24000001 Solicitation number
- Contract value 100% obligated
- $993,161.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $700,000 | |
| Original award | $293,161 |
About this award
The National Institutes of Health Clinical Center awarded a $993,161 firm fixed-price delivery order to Cardinal Health 414, LLC for radiopharmaceutical products and services, with performance concluding September 30, 2026. Cardinal Health 414, a subsidiary of Cardinal Health, Inc. headquartered in Dublin, Ohio, is a specialized supplier of nuclear medicine and diagnostic imaging products including technetium-99m, iodine-123, fluorine-18 fluorodeoxyglucose (FDG), and other critical radiopharmaceutical compounds. The award was made on an unrestricted basis with no set-aside designation and carries a firm fixed-price structure. Work will be performed at the contractor's facility in Dublin, Ohio.
Cardinal Health 414 maintains extensive established relationships with federal healthcare agencies as a critical single-source supplier of time-sensitive radiopharmaceutical products. The company holds multiple Indefinite Delivery Contracts and Blanket Purchase Agreements across the Veterans Affairs system, the Defense Health Agency, and the National Institutes of Health, with ceiling values ranging from approximately $88,000 to $7.5 million. The company's portfolio demonstrates compliance with stringent regulatory requirements including Nuclear Regulatory Commission licensing and FDA approval for radiopharmaceuticals, and the firm is positioned to meet demanding delivery timelines often requiring one to one-and-a-half hour turnaround times to accommodate the short half-lives of radioactive isotopes essential for oncology treatment and diagnostic imaging services across the federal healthcare infrastructure.
Quick answers
Who was awarded contract 75N90024F00001?
75N90024F00001 was awarded to Cardinal Health 414, LLC by NIH Clinical Center (National Institutes of Health) on October 1, 2022.
How much is contract 75N90024F00001 worth?
The government has obligated $993,161 on 75N90024F00001.
Is contract 75N90024F00001 an order under another contract?
Yes. 75N90024F00001 is a delivery order under 75N90023D00003, an indefinite delivery contract.
Was contract 75N90024F00001 competed?
The extent of competition for 75N90024F00001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award